Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesis

CoS (Schmidt C.) and FW have filed patent application on TASK-1-based gene therapy and pharmacotherapy of atrial arrhythmias. CoS received research funding from Boehringer Ingelheim. All other authors report no conflict of interest regarding the publication of this article.

Source: Heart Rhythm - April 2, 2024 Category: Cardiology Authors: Philipp Hegner, Manuel Schuh, Felix Wiedmann, Daniele Camboni, Christof Schmid, Lars Siegfried Maier, Constanze Schmidt, Stefan Wagner Source Type: research